Inhaled COVID-19 Vaccine Approved in China as Profits of Vaccine Giant Plummet

, --September 17, 2022

| Comments | Reader Friendly | Subscribe | Email Us


China’s State Drug Administration granted approval of an inhaled COVID-19 vaccine for emergency use as a booster vaccine last week. Vaccine manufacturer CanSino Biologics made the announcement on Sept. 4, saying it had developed and obtained approval for an inhalable COVID-19 vaccine after a proposal by China’s National Health Commission. The vaccine, called Convidecia, uses a recombinant adenovirus that is unable to replicate.-- More...

View Comments
Epoch Times——

The Epoch Times: “A Fresh Look at Our Changing World”

The Epoch Times is a privately held news media company. The center is in New York, but our network of local reporters throughout the world uncovers stories that are authentically local, yet also globally relevant. Our independence enables us to report widely and present a diversity of opinions.

 

We have offices in 30 countries across five continents, and our content is published in 17 languages. We are proud to offer print and web editions in Chinese, English, German, French, Spanish, Hebrew, Russian, Japanese, Korean and Indonesian, as well as web versions in Ukrainian, Bulgarian, Romanian, Czech, Slovak, Vietnamese and Swedish.